Immunological processes have been thought to play a role in rheumatoid arthritis, but no conclusive evidence has yet been obtained. Rheumatoid factor (RA factor) is known to be an antibody-like protein frequently found in the sera of patients with rheumatoid arthritis, but it has not been proved that it has any immediate relationship with the inflammatory processes of the disease, and the specific 'auto-antibody ' has not yet been detected.
However, many biological phenomena, which take place in immunological reactions are caused not only by the specific antibody but also by nonspecific serum factors such as those of the complement system or the fibrinolysin system.
The complement system is a group of serum proteins consisting of nine components designated Cl, C4, C2, C3, C5, C6, C7, C8, and C9 (Nelson, Jensen, Gigli, and Tamura, 1966; Miiller-Eberhard, 1965) , which interact with antigen-antibody complexes in this sequence.
Cl is activated by antigen-antibody complexes and acquires esterase activity which destroys C4 and C2 (Lepow, Ratnoff, Rosen, and Pillemer, 1956 ). It also enhances the permeability of the walls of capillary vessels (Dias da Silva and Lepow, 1965) .
C4 is a component which reacts with antigenantibody Cl complexes. It is identified antigenically as iE globulin (Muller-Eberhard and Biro, 1963) .
C3 is activated by the effect of activated C4, C2 complexes (Miuller-Eberhard, Polley, and Calcott, 1967) and acquires peptidase activity (Cooper and Becker. 1967) . Activated C3 causes some important immunological reactions, such as immune adherence (Nishioka, 1963) and immune phagocytosis (Nelson, 1953) . C3 is identified antigenically as 3,1c globulin by immune electrophoresis (MullerEberhard and Nilsson, 1960) . C3 and C5 are the components which participate in an anaphylatoxin generation, and are thought to play an important role in immune pathological procedures (Jensen, 1967 ; Dias da Silva and . C5, C6, and C7 are said to take part in the formation of a chemotactic substance, causing accumulations of polymorphonucleocytes (Ward, Cochrane, and Miiller-Eberhard, 1966) .
When all nine components of complement have reacted, immune cytolysis, such as immune haemolysis (Borsos, Dourmashkin, and Humphrey, 1964) , the serum bactericidal reaction (Muschel and Treffers, 1956) , and the lysis of certain tumour cells (Green, Barrow, and Goldberg, 1969) , takes place.
The complement system thus plays very important roles in the inflammatory processes of immunological reactions.
It is interesting to clarify the state of the complement system in so-called immune diseases such as rheumatoid arthritis. In rheumatoid arthritis, the levels of complement activity in synovial fluids are said to be diminished compared with those in other joint diseases (Pekin and Zvaifler, 1964, Hedberg, 1963) . In order further to explore the mechanisms of this intra-articular complement depletion in rheumatoid arthritis, the nine components of complement were measured. Some of them were shown to exist in inactivated forms in rheumatoid synovial fluids, suggesting the local utilization of the complement system in the development of this disease.
Material and Methods

SYNOVIAL FLUIDS
These were obtained from patients with rheumatoid arthritis, osteoarthritis, and other arthritides.
Nineteen patients with rheumatoid arthritis fulfilled the American Rheumatoid Association's criteria for definite or classical rheumatoid zrthritis. They represented all degrees of disease activity, and had received many different therapeutic agents, including salicylates, phenylbutazone, gold salts, indomethacine, and cortico,teroids.
Seventeen patients with osteoarthritis had a characteristic history of noninflammatory arthritis and typical radiological and synovial fluid findings.
Twelve patients with other arthritic conditions, including gouty, post-traumatic, and infectious arthritis, had acute arthritis and/or characteristic histories.
Complement components in synovial fluids in rheumatoid arthritis 165 Synovial fluids were obtained by aseptic aspiration of the suprapatellar pouch, immediately placed in an ice box, and then centrifuged at 00 C. for 15 min. at 3,000 rpm. The supernatant fluids were kept at -70°C. in an electric deep-freezer until the titrations were performed. Before titration, the synovial fluids were treated with 50 units hyaluronidase per ml. fluid at 370 C. for 10 min. This procedure had no effect on the complement system. DILUENTS GVB + + (gelatin veronal buffer) containing 0 * 1 per cent. gelatin (Difco), 0 00015 M Ca++, and 0-0005 M Mg++ was prepared (Mayer, 1961) . Glucose-GVB + + (glucosegelatin veronal buffer; gl-GVB + +) was made by mixing gelatin veronal buffer containing twice the usual amounts of Ca + + and Mg + + with an equal volume of 5 per cent. glucose in distilled water (Inoue and Nelson, 1965) . Two different concentrations of ethylenediaminetetraacetate (EDTA)-GVB, containing 0 04 and 0-01 M EDTA, were used.
SHEEP ERYTHROCYTE (E), AMBOCEPTOR (A), AND SENSITIZED SHEEP ERYTHROCYTE (EA)
The source and preparation of sheep erythrocyte (E), rabbit antibody to boiled stroma of sheep erythrocyte (A), and sensitized sheep erythrocyte (EA) are given by Mayer (1961) .
PREPARATION OF INTERMEDIATE COMPLEX
Sensitized sheep erythrocytes with first and fourth components of guinea-pig complement (EAC1&P4SPcell), sensitized sheep erythrocytes with first component of guinea-pig (EAC1gPcell) and human (EAClhUcell) complement, and sensitized sheep erythrocytes with fourth component of guinea-pig (EAC4sPcell) complement were prepared as described by Nelson and others (1966) and Nishioka and Linscott (1963) .
Intermediate complex of sensitized sheep erythrocytes with first component of guinea-pig complement and fourth component ofhuman complement (EAC1 P4hucell) was prepared as follows: To EA cells suspended in gl-GVB + +, were added 1,000 effective molecules per cell of Cl"P. The mixture was incubated at 30G C. for 20 min. and 00 C. for 20 min. and then washed three times and resuspended in gl-GVB + + (EACIgPcell). These EAC1gP cells were mixed with 500 effective molecules per cell of purified C4hu. The mixture was incubated at 370 C. for 20 min. and the cells were washed three times with gl-GVB + + (EACI P4hUcell). The cells were stored at 0 to 20 C. after the addition of 100 units penicillin and 100 jig. streptomycin/ml. Before use, they were washed with suitable diluent to remove the antibiotics. Stoichimetric titration of C1, C4, and C2 in all samples to be tested was performed essentially as described by Nelson and others (1966) and Mayer (1961) .
Titration of C4 was performed as follows: Sample dilutions, 0 * 2 ml. in gl-GVB + +, were incubated with 0-2 ml. EAClgPcell (1 x 108/ml.) for 10 min. at 30°C. 0-2 ml purified C2SP (100 eff. mole/cell) were then added and incubated for another 10 min. at 300 C., followed by the addition of 0 * 6 ml. 1 : 37 * 5 complement-EDTA and further incubation at 370 C. for 60 min. Then 1-6 ml. cold 0 01 M EDTA-GVB were added to each tube, thoroughly mixed, and centrifuged. Oxyhaemoglobin contents of the supernatants were measured at 414 mto.
Cl and C2 were titrated employing EAC49Pcell and EACl1P4hUcell (Tamura and Jensen, 1966) respectively.
TITRATION OF OTHER COMPONENTS
C3, C5, C6, C7, C8, and C9 were assayed by immune haemolysis according to the method of Nelson and others (1966) , using the microtitre technique described by Torisu, Arata, Sonozaki, and Majima (1967) , except that EAC19PC4hucell was used for C3 titration, because human C3 was more reactive with EAClgPC4huC29P cell than with EAC1gPC49PC29Pcell (Shimada, Sekine, Mayumi, and Miyakawa, 1969) .
PURIFIED COMPONENTS OF COMPLEMENT
The first component of guinea-pig (C19P) and human (Clhu) complement was precipitated at pH 7 *5, as described by Nelson and others(1966) . Furtherpurification was obtained by reprecipitation under the same conditions. The fourth component of human complement (C4hU) was separated from the remaining fraction during the separation of C3 inactivator as described by Torisu, Sonozaki, Shiraishi, and Nishioka (1968) . It was purified from human serum using column chromatography on diethylaminoethyl (DEAE) cellulose and carboxymethyl (CM) cellulose followed by Pevikon C870 zone electrophoresis and Sephadex G-200 superfine gelfiltration. Highly purified C4hU was prepared in collaboration with Dr. M. Matsuura and Dr. S. Takizawa. Purifications of other guinea-pig components of complement were carried out by the method of Nelson and others (1966) .
Rabbit anti-16lE globulin antiserum was kindly prepared by Dr. S. Inai as follows:
0-85 mg. crystallized egg albumin (5 x recrystallized, Nutritional Biochemicals Corporation, Cleveland, Ohio) was added to the equivalent dose of an antirabbit serum (1 ml.) in the presence of 0-01 M EDTA and the mixture was kept at 40 C. for 24 hrs. The precipitate was obtained by centrifugation at 6,000 rpm for 15 min., and washed twice with 0 -01 M EDTA and twice with saline. The precipitate was resuspended in saline to contain 376 pg.N/ml. 1 ml. of this immune complex was added to 1-4 ml. ClgP(l *8 x 1011eff. mol) in the presence of GVB-Ca + +, and incubated at 300 C. for 20 min. After centrifugation, the precipitate was washed once with GVB-Ca + +, and resuspended in the original volume of GVB-Ca + +. 1 ml. of this egg albumin-antiegg albuminCl-complexes was added to 2 5 mg. (4 3 x 1013eff. mol) C4hu and incubated at 300 C. for 30 min. The precipitate was separated by centrifugation and the supematant fluid was treated again with another 1 ml. of the same immune precipitate. The precipitate thus obtained was washed once with GVB-Ca++, and then treated with 0 -04 EDTA-GVB to eliminate the first component of complement. By these procedures, 4-3 x1013 eff. mol C4hu was found to be exhausted with the addition of 4,000 pg.N of egg albumin-antiegg albumin complexes.
The final product was resuspended in saline so as to contain 200 ,ug.N/ml. and used for the immunization.
The egg albumin-antiegg albumin-C4 complex, prepared as described above, was injected into two rabbits; three times intravenously and twice intradermally into the foot pad and dorsum, at intervals of 3 to 4 days. 10 days after the last injection, the rabbits were bled and the sera were collected. These antisera gave a single precipitin line against whole human serum and purified C4 upon immunoelectrophoresis and Ouchterlony's double diffusion test.
PREPARATION OF ANTISERUM TO C3hu
Two rabbits were injected into the foot pad with 1 mg.
highly purified C3hU (P,c globulin) 
Results
Synovial fluid complement activities The diagnoses of joint disease, synovial fluid total protein concentrations, and complement activities are shown in Table I , II, and III.
The synovial fluid complement activities in osteoarthritis were relatively low, having a median value of 10 1 CH50 (Table J) . The synovial fluid complement activities of the patients with gout, posttraumatic arthritis, or other forms of acute arthritis were significantly high, having a median value of 15 * 1 CH50 (Table II) .
Thirteen synovial fluid complement values in nineteen patients with rheumatic arthritis revealed significantly low titres and in one-third the complement activity was less than 1 CH50.
CIA50 values corresponded well with haemolytic complement activities in every case. Complement components in synovial fluids in rheumatoid arthritis 169 CS, and C6, these were far less remarkable than in the case of C4. It was therefore concluded that the low complement reactivity of rheumatoid synovial fluids was mainly due to the depletion of C4 activity.
Immunoelectrophoretic anialysis of C4 in synovial fluid C4 is said to have antigenic property as flE globulin. flE globulin was therefore tested immunoelectrophoretically using eight cases of synovial fluids with low C4 reactivity.
In one out of eight cases of rheumatoid arthritis (Case 31), flE globulin precipitin line was hardly observed, indicating the depletion of this substance.
But the other seven cases showed distinct PE precipitin lines as well as the normal control serum, indicatingthe adequate amount of PIE globulin in these synovial fluids (Fig. 2) Other troughs: Anti-3i globulin rabbit serum. Semiquantitative measurements of PIE globulin were performed using the double diffusion method. Serial dilutions of synovial fluids from rheumatoid arthritis and osteoarthritis were made, and the maximum dilutions which produced the distinct precipitin line were determined. No differences were observed in the amounts of PIE globulin in each synovial fluid (Table VI) . From these observations, it appears that many parts of PE globulin in rheumatoid synovial fluids are changed to a haemolytically inactive form.
Measurement of Plc (1A) globulin
The Pic globulin is said to have a close relationship with C3. The amounts of Pc antigenicity were therefore measured using Partigen plates. As shov. n in Fig. 3 (Fig. 4) . This report supports the concept that, in the affected joint spaces, C3 is used and inactivated in cases of rheumatoid arthritis. Normal whole human serum was stored at -700 C. for about 2 months.
Upper trough: Anti-813c globulin rabbit serum. Middle trough: Anti-P,c globulin rabbit serum.
Lower trough: Horse anti-whole human serum (Osaka Microbial Diseases Research Foundation, Lot No. 6).
Latex-fixation test (LFT) of synovial fluids
The results of the LFT are shown in Table I, II, and III. No relationship between complement activity and LFT titre was observed.
Discussion
It is said that in rheumatoid arthritis the level of serum complement is slightly elevated, whereas the titre in joint effusions is strikingly diminished in comparison with other joint diseases (Pekin and Zvaifler, 1964; Hedberg, 1963) . Our observations support these findings: the concentration of 6-12 CH50 units per ml. synovial fluid in thirteen patients with osteoarthritis was roughly one-fourth the serum CH50 concentration, which is 36-43±5*47 (Torisu, Arata, and Majima, 1966) . The synovial fluid CH50 levels in cases of acute arthritis, such as gouty or post-traumatic arthritis, were higher. The concentration of 0-3 CH5, units was much lower in synovial fluids from thirteen patients with rheumatoid arthritis.
Like Pekin and Zvaifler (1964) and Hedberg (1963) we found a direct relationship between the protein concentration and the complement activity of synovial fluid from non-rheumatoid joint diseases. But the complement activity in rheumatoid fluids did not correlate with the protein concentration as is shown in Fig. 1 . This seems to suggest that the rheumatoid factor has an anticomplementary activity, but no relationship between rheumatoid factor and haemolytic complement activity was observed in the present study. Therefore, rheumatoid factor could not be held to account for the depletion of complement activity in synovial fluids from rheumatic patients.
In order to explore the mechanism of this apparent intra-articular complement depletion in RA, measurements of nine components of complement were performed. The result indicated that C4 was strikingly low as compared with other complement components (Table V) . Some diminutions in the activity of C2, C3, C5, C6 were also observed, but these were much less marked. The lowered total haemolytic complement activity in RA synovial fluid was thus accounted for by the low activity of C4. It is known that C4 is the complement component which is most depleted by the complementfixation test.
Inai, Fujikawa, Nagaki and Takahashi (1967) reported a decrease in C4 in the sera of some patients, especially those with chronic myelogenous leukaemia and liver cirrhosis. This finding suggests that the complement system loses its haemolytic activity in rheumatoid joint spaces.
Further to explore the mechanism of C4 depletion in RA synovial fluid, the antigenicity of C4, PIE globulin, was tested by immunoelectrophoresis using these low C4 fluids. As described above seven of eight low C4 fluids gave clear precipitin lines against anti-Pi,E rabbit serum, indicating the existence of high levels of PiE globulin. These results were confirmed by semiquantitative measurements (Table VI) . This result shows that C4 can enter into the joint spaces in RA. but loses its activity and exists in an inactivated form; i.e. treatment of C4 with Cl esterase results in its conversion to the haemolytically inactive product C4i (MullerEberhard and Lepow, 1965 (Fig. 4) .
group.bmj.com on August 15, 2017 -Published by http://ard.bmj.com/ Downloaded from Complement components in synovial fluids in rheumatoid arthritis 171 PIC (1A) antigenicity was measured in some synovial fluids by using Partigen plates. As described above (Fig. 3) , the IC (P1A) antigenicity had a good correlation with C3 activity in non-RA fluids, but was relatively low in RA fluids. This indicates that in RA fluids some parts of C3 exist in an inactivated form, and suggests that the complement system is utilized in the inflammatory processes.
Summary
Total haemolytic complement activity is relatively low in synovial fluids from patients with rheumatoid arthritis despite the high concentrations of total protein.
The presence of nine components of complement in synovial fluids was demonstrated.
The activity of the fourth complement component (C4) was much lower in synovial fluid from rheumatoid arthritis patients than in fluids from patients with degenerative joint disease. However, the levels of PlE globulin in these fluids with a low C4 component were not so low as might be expected, indicating the presence of an inactivated form of C4 in such fluids. La actividad del complemento hemolitico absoluto se halla relativamente baja en los fluidos sinoviales de pacientes con poliartritis reumatoide, a pesar de las altas concentraciones de proteina absoluta. Se demostr6 la presencia de nueve componentes en los fluidos sinoviales.
La actividad del cuarto componente de complermento (C4) fue mucho mAs baja en el fluido sinovial de pacientes con poliartritis reumatoide que en fluidos de pacientes con enfermedad articular degenerativa. No obstante, los niveles de globulina P,E en estos fluidos con escaso componente C4 no eran tan bajos como podria esperarse, lo cual indicaba la presencia de una forma inactivada de C4 en tales fluidos. El nivel de globulinafl.c en los fluidos sinoviales fue medido usando inmunoplacas de partigeno. Se observ6 una discrepancia entre la actividad del C3 y la cantidad de globulina P c#ICA) en fluidos de pacientes con poliartritis reumatoide. Estos tesultados senialan la presencia de mAs altas cantidades de C3 (globulina P8A) inactivado en fluido sinovial de pacientes reumatoides, que en fluido de casos de enfermedad articular de-enei ativa. Estas observaciones indican que estos componentes de complemento son utilizados en los espacios articulares de pacientes con poliartritis reumatoide.
